03835nas a2200301   4500008004100000022001400041245015300055210006900208260001200277520274700289653005303036653004003089653003503129653003403164653003303198653003503231100002003266700002203286700002603308700002103334700001903355700002103374700001903395700002603414700002103440700002403461856004803485       2015                        eng d  a1872-895200aP300-based brain-computer interface (BCI) event-related potentials (ERPs): People with amyotrophic lateral sclerosis (ALS) vs. age-matched controls.0 aP300based braincomputer interface BCI eventrelated potentials ER  c02/20153 a<p><b>OBJECTIVE: </b>Brain-computer interfaces (BCIs) aimed at restoring communication to people with severe neuromuscular disabilities often use event-related potentials (ERPs) in scalp-recorded EEG activity. Up to the present, most research and development in this area has been done in the laboratory with young healthy control subjects. In order to facilitate the development of BCI most useful to people with disabilities, the present study set out to: (1) determine whether people with amyotrophic lateral sclerosis (ALS) and healthy, age-matched volunteers (HVs) differ in the speed and accuracy of their ERP-based BCI use; (2) compare the ERP characteristics of these two groups; and (3) identify ERP-related factors that might enable improvement in BCI performance for people with disabilities.</p><p><b>METHODS: </b>Sixteen EEG channels were recorded while people with ALS or healthy age-matched volunteers (HVs) used a P300-based BCI. The subjects with ALS had little or no remaining useful motor control (mean ALS Functional Rating Scale-Revised 9.4 (±9.5SD) (range 0-25)). Each subject attended to a target item as the items in a 6×6 visual matrix flashed. The BCI used a stepwise linear discriminant function (SWLDA) to determine the item the user wished to select (i.e., the target item). Offline analyses assessed the latencies, amplitudes, and locations of ERPs to the target and non-target items for people with ALS and age-matched control subjects.</p><p><b>RESULTS: </b>BCI accuracy and communication rate did not differ significantly between ALS users and HVs. Although ERP morphology was similar for the two groups, their target ERPs differed significantly in the location and amplitude of the late positivity (P300), the amplitude of the early negativity (N200), and the latency of the late negativity (LN).</p><p><b>CONCLUSIONS: </b>The differences in target ERP components between people with ALS and age-matched HVs are consistent with the growing recognition that ALS may affect cortical function. The development of BCIs for use by this population may begin with studies in HVs but also needs to include studies in people with ALS. Their differences in ERP components may affect the selection of electrode montages, and might also affect the selection of presentation parameters (e.g., matrix design, stimulation rate).</p><p><b>SIGNIFICANCE: </b>P300-based BCI performance in people severely disabled by ALS is similar to that of age-matched control subjects. At the same time, their ERP components differ to some degree from those of controls. Attention to these differences could contribute to the development of BCIs useful to those with ALS and possibly to others with severe neuromuscular disabilities.</p>10aalternative and augmentative communication (AAC)10aamyotrophic lateral sclerosis (ALS)10aBrain-computer interface (BCI)10abrain-machine interface (BMI)10aelectroencephalography (EEG)10aevent-related potentials (ERP)1 aMcCane, Lynn, M1 aHeckman, Susan, M1 aMcFarland, Dennis, J.1 aTownsend, George1 aMak, Joseph, N1 aSellers, Eric, W1 aZeitlin, Debra1 aTenteromano, Laura, M1 aWolpaw, Jonathan1 aVaughan, Theresa, M  uhttp://www.ncbi.nlm.nih.gov/pubmed/2570394002447nas a2200229   4500008004100000022001400041245007700055210006700132260001200199300001400211490000800225520176000233653002901993653002002022653000902042100002602051700002602077700002102103700002402124700002102148856004802169       2011                        eng d  a1872-895200aThe P300-based brain-computer interface (BCI): effects of stimulus rate.0 aP300based braincomputer interface BCI effects of stimulus rate  c04/2011  a731–7370 v1223 aOBJECTIVE:
Brain-computer interface technology can restore communication and control to people who are severely paralyzed. We have developed a non-invasive BCI based on the P300 event-related potential that uses an 8×9 matrix of 72 items that flash in groups of 6. Stimulus presentation rate (i.e., flash rate) is one of several parameters that could affect the speed and accuracy of performance. We studied performance (i.e., accuracy and characters/min) on copy spelling as a function of flash rate.
METHODS:
In the first study of six BCI users, stimulus-on and stimulus-off times were equal and flash rate was 4, 8, 16, or 32 Hz. In the second study of five BCI users, flash rate was varied by changing either the stimulus-on or stimulus-off time.
RESULTS:
For all users, lower flash rates gave higher accuracy. The flash rate that gave the highest characters/min varied across users, ranging from 8 to 32 Hz. However, variations in stimulus-on and stimulus-off times did not themselves significantly affect accuracy. Providing feedback did not affect results in either study suggesting that offline analyses should readily generalize to online performance. However there do appear to be session-specific effects that can influence the generalizability of classifier results.
CONCLUSIONS:
The results show that stimulus presentation (i.e., flash) rate affects the accuracy and speed of P300 BCI performance.
SIGNIFICANCE:
These results extend the range over which slower flash rates increase the amplitude of the P300. Considering also presentation time, the optimal rate differs among users, and thus should be set empirically for each user. Optimal flash rate might also vary with other parameters such as the number of items in the matrix.10abrain-computer interface10aneuroprosthesis10aP3001 aMcFarland, Dennis, J.1 aSarnacki, William, A.1 aTownsend, George1 aVaughan, Theresa, M1 aWolpaw, Jonathan  uhttp://www.ncbi.nlm.nih.gov/pubmed/21067970